Akeso’s Ivonescimab Shows Promising Results in Phase III Clinical Trial for Hepatocellular Carcinoma
Akeso Inc. (HKG: 9926), a biopharmaceutical company based in China, has announced that its first-in-class...
AstraZeneca Faces Investigation in China Over Data Privacy and Unapproved Drugs
AstraZeneca (NASDAQ: AZN), a leading UK pharmaceutical company, is reportedly under the spotlight in Shenzhen,...
U.S. House of Representatives to Review the Biosecure Act Amid Legislative Hurdles
The U.S. House of Representatives is slated to take up the contentious Biosecure Act the...
Eli Lilly Partners with Genetic Leap for RNA-Targeted AI Drug Discovery
Eli Lilly & Co. (NYSE: LLY), a leading pharmaceutical company based in the U.S., has...
Euroapi to Downsize API Production, Citing Asian Competition and Market Stagnation
Euroapi (EPA: EAPI), a French company and a spinoff from Sanofi established in 2022, has...
Rigel Pharmaceuticals Strikes Deal with Kissei for Development and Commercialization of Rezlidhia in East Asia
Rigel Pharmaceuticals Inc. (NASDAQ: RIGL), a biopharmaceutical company based in the U.S., has entered into...
Sinocelltech’s Herpes Zoster Vaccine SCTV04C Clears NMPA for Clinical Trial
Sinocelltech Group Ltd (SHA: 688520), a biopharmaceutical company based in China, has received approval from...
Voyager Therapeutics Secures Licensing Deal with Novartis for Gene Therapy Capsid
Voyager Therapeutics Inc. (NASDAQ: VYGR), a U.S.-based biotechnology company, has announced a licensing agreement with...
Fujirebio’s HBsAg Detection Kit Receives NMPA Approval, Enhances Early Diagnosis Capabilities
Fujirebio Inc., a leading diagnostic company based in Japan, has received approval from China’s National...
Jiangsu Kanion Pharmaceutical Gets NMPA Go-Ahead for Psoriasis Drug Clinical Trial
Jiangsu Kanion Pharmaceutical Co., Ltd (SHA: 600557), a prominent pharmaceutical company based in China, has...
Genesis MedTech Secures NMPA Approval for Innovative Surgical Energy Products
Genesis MedTech, a leading medical device company headquartered in Singapore, has secured marketing approvals from...
True Health’s Advanced Microwave Ablation System Gains NMPA Nod for Liver Tumor Treatment
True Health (Guangdong Hengqin) Medical Technology Co., Ltd has received marketing approval from China’s National...
Venus Medtech Initiates Global Study with Venus Vitae TAVR System Implantations
Venus Medtech (Hangzhou) Inc., listed on the Hong Kong Stock Exchange as HKG: 2500, has...
China’s Hainan Free Trade Port Implements ‘Zero Tax’ on Medical Imports for Designated Entities
In a joint effort to bolster healthcare services, China’s Ministry of Finance, National Health Commission...
Viatris Launches First-of-Its-Kind Nasal Spray Dymista in China for Allergic Rhinitis
Viatris Inc. (NASDAQ: VTRS), a leading global pharmaceutical company based in the U.S., has announced...
Sansure Biotech Wins NMPA Nod for ALDH2 Gene Polymorphism Detection Kit
Sansure Biotech Inc., (SHA: 688289), a leading molecular diagnostics company based in China, has announced...
Novo Nordisk Advances in China with Submission of Sogroya for Adult Growth Hormone Deficiency
Denmark’s pharmaceutical heavyweight, Novo Nordisk (NYSE: NVO), has reached a significant milestone with the National...
AstraZeneca China Restructures Biopharma Unit to Boost Chronic Disease Management
AstraZeneca (NASDAQ: AZN)’s Chinese subsidiary has announced a strategic restructuring of its China biopharmaceutical business...
Kelun-Biotech’s ADC for Cancer Gets NMPA Review, Expands MSD Collaboration
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd (HKG: 6990) has achieved a regulatory milestone with its clinical...
Eli Lilly Partners with Haya Therapeutics to Tap the Dark Genome for Obesity Treatments
Eli Lilly & Co. (NYSE: LLY), a leading figure in the pharmaceutical industry, has embarked...